基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the complete record of transactions filed by Anderman Jonathan. Insider active across 1 company, notably Compass Therapeutics, Inc.. In total, 4 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €69k. Activity tracked since 7 April 2025. The latest transaction was disclosed on 29 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Anderman Jonathan is a declarant linked to Compass Therapeutics, Inc. (XNAS), where he is General Counsel. Across 4 filings in total, the sampled recent filings cover the period from 2025-04-08 to 2026-04-30, with EUR 68655 of purchases and EUR 0 of sales.